Treatment for Bell palsy (a condition involving the facial nerve and characterized by facial paralysis) with the corticosteroid prednisolone within 72 hours appeared to significantly reduce the number of patients with mild to moderate palsy severity at 12 months.

Muscular Dystrophy Association has awarded ReveraGen BioPharma $1.5 million to develop drug TUCSON, Ariz., May 3, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association

Mouthguards are used by almost everyone participating in sports.

Funds Will Support Testing of Anti-Inflammatory Compounds in Mice TUCSON, Ariz.

Research by Columbia Business School's Modupe Akinola, Assistant Professor, Management, and Wendy Berry Mendes, Associate Professor, Sarlo/Ekman Endowed Chair of Emotion, University of California San Francisco in Behavioral Neuroscience examines how increases in cortisol, brought on by an acute social stressor, can influence threat-related decision making.